Biotech stocks fell 28% this week from their July peak. Saxo's Peter Garnry on why no-one is talking about the crash and why he's still positive on the sector.
from Peter Garnry - Authored content http://ift.tt/1N3Fbyn
via IFTTT
Garnry: Why no-one is talking about the crash in biotech stocks
ad
Enregistrer un commentaire